🇰🇷 MANGAFODIPIR in South Korea

MANGAFODIPIR (MANGAFODIPIR) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

MANGAFODIPIR in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Gastroenterology approved in South Korea

Frequently asked questions

Is MANGAFODIPIR approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for MANGAFODIPIR in South Korea?

Marketing authorisation holder not available in our data.